{
  "main_header": {
    "sid": 1003728,
    "name": "Piramal Pharma",
    "stock_name": "Piramal Pharma",
    "full_name": "Piramal Pharma Ltd",
    "name_url": "stocks-analysis/piramal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "169.30",
    "chg": 2.8,
    "chgp": "1.68%",
    "dir": 1,
    "prev_price": "166.50",
    "mcapval": "22,504.17 Cr",
    "mcap": "Small Cap",
    "scripcode": 543635,
    "symbol": "PPLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0DK501011",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "21.52 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/piramal-pharma-1003728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Piramal Pharma Stock Falls to 52-Week Low of Rs.165.05 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-falls-to-52-week-low-amidst-continued-downtrend-3762542",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3762542.png",
        "date": "2025-12-18 10:15:49",
        "description": "Piramal Pharma's shares reached a new 52-week low of Rs.165.05 today, marking a significant decline as the stock continues to trade below all key moving averages. This latest low reflects ongoing pressures on the company’s financial performance and market valuation within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Piramal Pharma Stock Falls to 52-Week Low of Rs.165.05 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-falls-to-52-week-low-amidst-continued-downtrend-3762539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3762539.png",
        "date": "2025-12-18 10:15:47",
        "description": "Piramal Pharma’s shares touched a fresh 52-week low of Rs.165.05 today, marking a continuation of the stock’s downward trajectory over recent sessions. The pharmaceutical company’s stock has declined over the past four trading days, reflecting a cumulative return of -5.27% during this period, underperforming its sector by 0.76% today."
      },
      {
        "title": "Piramal Pharma Stock Falls to 52-Week Low of Rs.167.5 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-falls-to-52-week-low-of-rs1675-amidst-continued-downtrend-3761489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3761489.png",
        "date": "2025-12-17 15:54:41",
        "description": "Piramal Pharma’s shares touched a fresh 52-week low of Rs.167.5 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Piramal Pharma Stock Falls to 52-Week Low of Rs.167.5 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-hits-52-week-low-amidst-continued-downtrend-3761491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3761491.png",
        "date": "2025-12-17 15:54:40",
        "description": "Piramal Pharma’s shares touched a fresh 52-week low of Rs.167.5 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Piramal Pharma Sees Revision in Market Evaluation Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3761069",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_mojoScore_3761069.png",
        "date": "2025-12-17 10:10:46",
        "description": "Piramal Pharma's market evaluation has undergone a revision reflecting shifts in its financial and technical outlook. The pharmaceutical company, classified as a smallcap within the Pharmaceuticals & Biotechnology sector, is navigating a period marked by subdued sales growth, profitability challenges, and technical indicators signalling caution for investors."
      },
      {
        "title": "Piramal Pharma Stock Falls to 52-Week Low of Rs.169.15 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-hits-52-week-low-amidst-continued-downtrend-3759850",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3759850.png",
        "date": "2025-12-16 09:57:59",
        "description": "Piramal Pharma's shares reached a fresh 52-week low of Rs.169.15 today, marking a significant decline amid ongoing downward momentum. The stock has been trading below all major moving averages and has underperformed its sector and benchmark indices over the past year."
      },
      {
        "title": "Piramal Pharma Stock Falls to 52-Week Low of Rs.169.75 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-falls-to-52-week-low-of-rs16975-amidst-continued-downtrend-3756358",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3756358.png",
        "date": "2025-12-11 10:08:22",
        "description": "Piramal Pharma has reached a new 52-week low of Rs.169.75, marking a significant decline as the stock continues its downward trajectory. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market factors that have influenced its recent performance."
      },
      {
        "title": "Piramal Pharma Stock Hits 52-Week Low at Rs.170.15 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-stock-hits-52-week-low-amidst-continued-downtrend-3755475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PiramalPharma_priceRelatedfactors_3755475.png",
        "date": "2025-12-10 15:40:46",
        "description": "Piramal Pharma’s shares touched a fresh 52-week low of Rs.170.15 today, marking a continuation of a sustained decline that has seen the stock fall by nearly 8% over the past six trading sessions. This latest low reflects ongoing pressures on the pharmaceutical company’s market performance amid broader sector and company-specific developments."
      },
      {
        "title": "Why is Piramal Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-piramal-pharma-fallingrising-3754517",
        "imagepath": "",
        "date": "2025-12-10 00:58:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>The stock has been on a consistent slide, losing 6.54% over the past week compared to a modest 0.55% decline in the Sensex. Over the last month, the stock’s fall has been even more pronounced at 13.04%, while the Sensex gained 1.74%. Year-to-date, Piramal Pharma’s shares have plummeted nearly 35%, starkly contrasting with the Sensex’s 8.35% rise. This trend extends over the last year as well, with the stock down 32.34% against the Sensex’s 3.87% gain. Even over three years, the stock’s 34.45% return trails the Sensex’s 36.16%, signalling persistent underperformance.</p>\n<p>On 09-Dec, the stock touched an intraday low of ₹170.4, marking a fresh 52-week low. It has now declined for five consecutive days, underperforming its sector by ..."
      }
    ],
    "total": 361,
    "sid": "1003728",
    "stock_news_url": "https://www.marketsmojo.com/news/piramal-pharma-1003728"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "17-Dec-2025",
      "details": "Please find enclosed Postal Ballot Notice intimation.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "17-Dec-2025",
      "details": "Please find enclosed Postal Ballot Notice intimation.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - FDA Inspection",
      "datetime": "11-Dec-2025",
      "details": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- FDA Inspection",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has declared <strong>1%</strong> dividend, ex-date: 16 Jul 25",
          "dt": "2025-07-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has announced <strong>5:46</strong> rights issue, ex-date: 02 Aug 23",
          "dt": "2023-08-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Piramal Pharma Stock Falls to 52-Week Low of Rs.165.05 Amidst Continued Downtrend

2025-12-18 10:15:49

Piramal Pharma's shares reached a new 52-week low of Rs.165.05 today, marking a significant decline as the stock continues to trade below all key moving averages. This latest low reflects ongoing pressures on the company’s financial performance and market valuation within the Pharmaceuticals & Biotechnology sector.

Read More

Piramal Pharma Stock Falls to 52-Week Low of Rs.165.05 Amidst Prolonged Downtrend

2025-12-18 10:15:47

Piramal Pharma’s shares touched a fresh 52-week low of Rs.165.05 today, marking a continuation of the stock’s downward trajectory over recent sessions. The pharmaceutical company’s stock has declined over the past four trading days, reflecting a cumulative return of -5.27% during this period, underperforming its sector by 0.76% today.

Read More

Piramal Pharma Stock Falls to 52-Week Low of Rs.167.5 Amidst Continued Downtrend

2025-12-17 15:54:41

Piramal Pharma’s shares touched a fresh 52-week low of Rs.167.5 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read More

Piramal Pharma Stock Falls to 52-Week Low of Rs.167.5 Amidst Continued Downtrend

2025-12-17 15:54:40

Piramal Pharma’s shares touched a fresh 52-week low of Rs.167.5 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read More

Piramal Pharma Sees Revision in Market Evaluation Amidst Challenging Financial Trends

2025-12-17 10:10:46

Piramal Pharma's market evaluation has undergone a revision reflecting shifts in its financial and technical outlook. The pharmaceutical company, classified as a smallcap within the Pharmaceuticals & Biotechnology sector, is navigating a period marked by subdued sales growth, profitability challenges, and technical indicators signalling caution for investors.

Read More

Piramal Pharma Stock Falls to 52-Week Low of Rs.169.15 Amidst Continued Downtrend

2025-12-16 09:57:59

Piramal Pharma's shares reached a fresh 52-week low of Rs.169.15 today, marking a significant decline amid ongoing downward momentum. The stock has been trading below all major moving averages and has underperformed its sector and benchmark indices over the past year.

Read More

Piramal Pharma Stock Falls to 52-Week Low of Rs.169.75 Amidst Continued Downtrend

2025-12-11 10:08:22

Piramal Pharma has reached a new 52-week low of Rs.169.75, marking a significant decline as the stock continues its downward trajectory. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market factors that have influenced its recent performance.

Read More

Piramal Pharma Stock Hits 52-Week Low at Rs.170.15 Amidst Prolonged Downtrend

2025-12-10 15:40:46

Piramal Pharma’s shares touched a fresh 52-week low of Rs.170.15 today, marking a continuation of a sustained decline that has seen the stock fall by nearly 8% over the past six trading sessions. This latest low reflects ongoing pressures on the pharmaceutical company’s market performance amid broader sector and company-specific developments.

Read More

Why is Piramal Pharma falling/rising?

2025-12-10 00:58:49

Recent Price Movement and Market Comparison

The stock has been on a consistent slide, losing 6.54% over the past week compared to a modest 0.55% decline in the Sensex. Over the last month, the stock’s fall has been even more pronounced at 13.04%, while the Sensex gained 1.74%. Year-to-date, Piramal Pharma’s shares have plummeted nearly 35%, starkly contrasting with the Sensex’s 8.35% rise. This trend extends over the last year as well, with the stock down 32.34% against the Sensex’s 3.87% gain. Even over three years, the stock’s 34.45% return trails the Sensex’s 36.16%, signalling persistent underperformance.

On 09-Dec, the stock touched an intraday low of ₹170.4, marking a fresh 52-week low. It has now declined for five consecutive days, underperforming its sector by ...

Read More

View All News